Armune BioScience
Armune BioScience appears to be a dormant or closed life sciences entity whose primary domain, Armune.com, is listed for sale on HugeDomains.com. No products, customers, team, or operational data are available in the source material.
- Company typePrivate
- Founded2005
- HeadquartersKalamazoo, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Armune BioScience does
Armune BioScience is referenced as an entity in the input data, but no substantive operational details are available. The company's brand name suggests a life sciences or biotechnology orientation, but the source materials contain no information on products, services, technology, customers, team, or funding. The only verifiable data point is that the domain Armune.com is listed for sale on HugeDomains.com at an asking price of $10,195, with the option of a 24-month payment plan at $424.79 per month. No active company website, social media profiles, or first-party corporate disclosures are present in the source.
The operating status in the structured data is flagged as "closed," consistent with the domain-for-sale listing and the absence of any active web presence. Legal entity information, incorporation jurisdiction, founded date, and ownership structure are all marked as unknown or unavailable. The data effectively limits any analytical conclusion to the observation that the company either is no longer operating, has been acquired without a public trace, or has migrated to a different domain/name. Without additional primary sources, the investment profile of Armune BioScience cannot be meaningfully characterized beyond its apparently inactive commercial footprint.
Armune BioScience firmographics
Firmographics- Name
- Armune BioScience
- Legal name
- Armune BioScience (legal name not specified in source)
- Website
- https://armune.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Closed
- Headcount range
- 11–50 employees
- Short description
- Armune BioScience appears to be a dormant or closed life sciences entity whose primary domain, Armune.com, is listed for sale on HugeDomains.com. No products, customers, team, or operational data are available in the source material.
- Ownership category
- akta.pro rank
Where Armune BioScience is headquartered
LocationHeadquarters
- HQ city
- Kalamazoo
- HQ country
- United States
- HQ region
- North America
Markets served
Armune BioScience business model
Business model- GTM type
- B2B
- Offering type
- Services
Armune BioScience product offering
Product offeringCore offering
No information is available about Armune BioScience's core offerings. The only source material is a HugeDomains.com domain marketplace listing indicating that Armune.com is for sale; no product or service details are provided.
Differentiator
Problem solved
Functional benefit
Armune BioScience technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Armune BioScience partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights5 records
Armune BioScience competitors and assessment
Company assessmentBroad incumbents
- Hologic: Hologic is a larger diagnostics and medical device company with cancer screening products including the ThinPrep Pap Test and molecular assays. It is a broad incumbent in the diagnostics space with overlapping cancer-focused offerings.
- Bio-Techne: Bio-Techne develops and manufactures proteins, reagents, and diagnostic tools used in life science research and clinical diagnostics. Its diagnostics division offers tools comparable to those underpinning Armune BioScience's biomarker work.
- NeoGenomics: NeoGenomics provides oncology-focused genetic and molecular diagnostic testing services to hospitals and clinicians. Its focus on cancer diagnostics makes it a broad incumbent comparable to Armune BioScience's intended market.
- Foundation Medicine: Foundation Medicine, now part of Roche, provides comprehensive genomic profiling of tumors. It operates in the cancer molecular diagnostics market that overlaps with Armune BioScience's intended diagnostic offerings.
- Myriad Genetics: Myriad Genetics is an established molecular diagnostics company offering tests such as Prolaris (prostate cancer) and BRACAnalysis. It serves overlapping oncology and urology customers with similar biomarker-driven diagnostic products, making it a broad incumbent peer.
Direct peers
- Guardant Health: Guardant Health is a leading liquid biopsy company focused on blood-based cancer diagnostics across multiple tumor types. Its blood-based detection platform is directly comparable to Armune BioScience's Apifiny approach.
- Natera: Natera develops cell-free DNA and molecular diagnostic tests, including Signatera for oncology monitoring. It operates in the same blood-based cancer diagnostics space as Armune BioScience.
- Veracyte: Veracyte develops genomic-based diagnostic tests for cancer, including urological indications such as the Decipher Prostate test. It competes in the same molecular oncology diagnostics niche as Armune BioScience.
- MDxHealth: MDxHealth specializes in molecular diagnostics for urological cancers, including the SelectMDx and ConfirmMDx tests for prostate cancer. It is a closely comparable peer in the prostate cancer diagnostics niche that Armune BioScience's Apifiny targeted.
- Exact Sciences: Exact Sciences develops non-invasive cancer screening and diagnostics tests, most notably Cologuard for colorectal cancer. It is a direct comparable to Armune BioScience in the blood- and biomarker-based cancer diagnostics space, particularly for urological/oncological indications.
Market position
Weaknesses1 record
Competitive moat1 record
Key risks2 records
Customer concentration
Armune BioScience social profiles
Digital presenceArmune BioScience financial estimates
Financial estimateRevenue estimate
Valuation estimate
Armune BioScience leadership team
Management profileNumber of profiles
Armune BioScience funding detail
Funding detailFunding overview
Funding rounds6 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Armune BioScience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Armune BioScience
What does Armune BioScience do?
No information is available about Armune BioScience's core offerings. The only source material is a HugeDomains.com domain marketplace listing indicating that Armune.com is for sale; no product or service details are provided.
Is Armune BioScience a public or private company?
Armune BioScience is a private company. It is classified as unknown and is currently closed.
When was Armune BioScience founded?
Armune BioScience was founded in 2005. It employs 11 to 50 people.
Where is Armune BioScience based?
Armune BioScience is headquartered in Kalamazoo, United States, in the North America region.
Who are Armune BioScience's main competitors?
Broad incumbents on record are Hologic, Bio-Techne, NeoGenomics, Foundation Medicine and Myriad Genetics. Direct peers are Guardant Health, Natera, Veracyte, MDxHealth and Exact Sciences.
Does Armune BioScience have an API?
No public API is recorded for Armune BioScience.